Huntington's Disease: Stroke Risk And Complications

Huntington's disease (HD) is an inherited neurodegenerative disorder that causes certain nerve cells in the brain to waste away. While it is a rare disease, it robs affected individuals of their physical and mental health. As the disease progresses, symptoms such as involuntary movements, emotional disturbances, and loss of intellectual abilities become more pronounced. Although Huntington's disease itself is not fatal, complications arising from the condition, such as infections or injuries related to falls, can lead to death. So, the question arises: can Huntington's disease cause a stroke?

Huntington's disease and risk of stroke

Huntington's disease (HD) is an inherited neurodegenerative disorder that causes certain nerve cells or neurons in the brain to waste away and die. It affects the cells in parts of the brain that regulate voluntary movement and memory. The disease attacks areas of the brain that help control voluntary movement, as well as other areas.

People with Huntington's disease develop uncontrollable movements and abnormal body postures, as well as problems with behaviour, emotion, thinking, and personality. These symptoms get worse over time. Early signs of HD may include uncontrolled movements, clumsiness, and balance problems. Later, it can take away the ability to walk, talk, and swallow.

HD affects a person's physical and mental health. Physical symptoms include uncontrolled movements like jerking or twitching (chorea), loss of coordination (ataxia), and difficulty swallowing (dysphagia). Emotional changes like mood swings, depression, and irritability are also common. Problems with memory, focus, and multitasking, as well as trouble learning new information and making decisions, are also symptoms of HD.

While HD itself is not fatal, people can die from its complications, such as infections like pneumonia or injuries related to falls. However, there is no direct evidence that HD causes strokes.

Huntington's disease and brain cell degeneration

Huntington's disease (HD) is a rare, inherited neurodegenerative condition that causes nerve cells in the brain to break down and die. HD is caused by a mutation in the single HTT gene, which interferes with the body's ability to produce a protein called huntingtin. While the function of huntingtin is not yet fully understood, it is found in nerve cells (neurons) in the brain and appears to build up inside neurons, causing them to die or malfunction.

HD affects the basal ganglia, a region of the brain responsible for coordinating movement, thought, memory, emotion, and perception. Within the basal ganglia, HD primarily affects the striatum, causing the death of a specific type of neuron called GABAergic spiny projection neurons. The degeneration of these neurons leads to a loss of muscle control, resulting in involuntary movements and abnormal body postures.

In addition to motor symptoms, HD also causes cognitive and behavioral changes. As the disease progresses, individuals may experience problems with thinking, memory, judgment, and decision-making. They may also exhibit mood swings, irritability, depression, and apathy. Eventually, the cognitive decline can lead to dementia.

The progression of HD can be influenced by environmental and genetic factors. The length of the CAG repeat expansion in the HTT gene is correlated with disease severity, with longer repeats leading to earlier onset and more rapid progression. However, other factors, such as genetic modifiers and environmental influences, also play a role in determining the age of onset and the specific symptoms that develop.

Currently, there is no cure or treatment to stop the progression of HD. However, certain medications can help manage some of the symptoms, including involuntary movements, psychiatric symptoms, and mood disturbances. While these treatments can provide some relief, they do not address the underlying cause of the disease.

Huntington's disease and movement

Huntington's disease (HD) is an inherited disorder that causes nerve cells (neurons) in parts of the brain to break down and die. The disease attacks areas of the brain that help to control voluntary (intentional) movement, as well as other areas. People with HD develop uncontrollable dance-like movements (chorea) and abnormal body postures.

The early signs of HD often include mild clumsiness or problems with balance or movement. For some people, chorea can make it harder to walk, increasing the chances of falling. Some people with HD do not develop chorea; instead, they may become rigid (stiff) and move very little or not at all. This condition is called akinesia. Other people may start out with chorea but become rigid as the disease progresses. In addition to chorea, some individuals have unusual fixed (unchanging) postures, which is known as dystonia. The two movement disorders (akinesia and dystonia) can blend or alternate. Other symptoms may include tremors and unusual eye movements.

The movement disorder of HD includes the emergence of involuntary movements (chorea) and the impairment of voluntary movements, which result in reduced manual dexterity, slurred speech, swallowing difficulties, problems with balance, and falls. Chorea typically progresses through the middle stages of HD but often declines as rigidity increases in the later stages.

There is no treatment that can stop or reverse HD, but some of the symptoms can be treated. The drugs tetrabenazine and deuterabenazine can treat chorea associated with HD. Antipsychotic drugs may ease chorea and help to control hallucinations, delusions, and violent outbursts. However, some antipsychotic medications can have side effects that make muscle contraction symptoms of HD worse.

Huntington's disease and mental health

Huntington's disease (HD) is an inherited neurodegenerative disorder that causes the breakdown and death of nerve cells in the brain. The disease affects both physical and mental health, with psychiatric symptoms often preceding motor and cognitive impairments.

Mental Health Symptoms

HD is associated with a wide range of psychiatric disturbances, including:

• Affective disorders
• Irritability
• Apathy
• Psychosis
• Depression
• Mood disturbances
• Anger
• Passivity
• Violent or paranoid behaviour
• Anxiety
• Suicidal thoughts

These symptoms can be managed with medications such as antidepressants and antipsychotics, but there is currently no cure for HD, and the disease is progressive.

Onset and Progression

The first symptoms of HD typically appear between the ages of 30 and 50, but can begin earlier (juvenile HD) or later. Once they start, symptoms usually worsen gradually. Psychiatric symptoms may appear years before the onset of motor symptoms, and can be an early indicator of HD.

As the disease progresses, cognitive problems intensify, often leading to dementia-like symptoms. Behavioural changes may also occur, such as social withdrawal and mood swings. In some cases, these symptoms may decrease as the disease progresses, but they can also continue and intensify.

Huntington's disease and treatment options

Huntington's disease is a rare, progressive neurodegenerative disorder that affects emotional, physical, and intellectual abilities. There is currently no cure or treatment to slow the progression of the disease. However, certain treatments can help manage the symptoms and improve patients' quality of life. Here are some treatment options for Huntington's disease:

• Medications: Drugs such as haloperidol, tetrabenazine, and amantadine can help control the unusual movements caused by the disease. Antidepressants and antianxiety medications may also be prescribed to treat depression and anxiety, which are common among those with Huntington's disease.
• Therapy: Physical therapy can help improve movement problems. Occupational therapy can assist patients in finding alternative ways to perform daily tasks and suggest equipment or home modifications to make their lives easier. Speech and language therapy, along with dietitian advice, can aid in communication and eating difficulties.
• Support services: Joining support groups or seeking counselling can provide emotional support and help patients cope with the challenges of the disease.
• Experimental therapies: Several experimental therapies are being investigated in clinical trials. These include gene silencing therapies, anti-inflammatory therapies, and neuroprotective therapies aimed at reducing nerve cell death.

Frequently asked questions